Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+3.15K
-
Total reported value, excl. options
-
$51.7M
-
Value change
-
-$3.44K
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$5.02
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2014
25 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2014.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 114M outstanding shares and own 8.99% of the company stock.
Largest 10 shareholders include FMR LLC (3.08M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.55M shares), WELLINGTON MANAGEMENT GROUP LLP (1.42M shares), ORBIMED ADVISORS LLC (693K shares), Board of Trustees of The Leland Stanford Junior University (291K shares), PRINCIPAL FINANCIAL GROUP INC (208K shares), VANGUARD GROUP INC (172K shares), Alyeska Investment Group, L.P. (76.5K shares), and GOLDMAN SACHS GROUP INC (73.4K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.